What is the recommended treatment for eczema (atopic dermatitis) in babies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Eczema in Babies

Regular emollients applied liberally at least twice daily plus low-potency topical corticosteroids (hydrocortisone 1%) for flares form the cornerstone of eczema management in babies. 1, 2

First-Line Treatment Strategy

Emollients (Essential Foundation)

  • Apply emollients liberally and frequently—at least twice daily and as needed throughout the day 2
  • Apply immediately after bathing to lock in moisture when skin is most hydrated 2
  • Use emollients regularly even when skin appears clear to maintain barrier function 1
  • Choose any formulation (lotion, cream, gel, or ointment) based on parent/child preference, as all types are equally effective 3
  • Ointments and creams are suitable for very dry skin or winter use 1

Bathing Technique

  • Bathe with lukewarm water for 10-15 minutes 1, 2
  • Replace soaps with gentle, dispersible cream cleansers as soap substitutes 2, 4
  • Apply emollients immediately after patting skin dry 1

Topical Corticosteroids for Flares

  • Use low-potency corticosteroids only (hydrocortisone 1%) for infants and babies 4, 5, 6
  • Apply once or twice daily to affected areas until lesions significantly improve 1, 5
  • Avoid high-potency or ultra-high-potency corticosteroids in infants due to increased risk of hypothalamic-pituitary-adrenal axis suppression from their high body surface area-to-volume ratio 4, 5
  • For face, neck, and skin folds, use only low-potency preparations to prevent skin atrophy 1, 4
  • Apply to affected areas not more than 3-4 times daily 6

Second-Line Options for Sensitive Areas

Topical Calcineurin Inhibitors

  • Pimecrolimus 1% cream is FDA-approved for babies as young as 3 months and is particularly useful for facial eczema 1, 5
  • Tacrolimus 0.03% ointment is approved for children aged 2 years and above 1, 5
  • These are steroid-sparing alternatives especially valuable for face and genital regions 4, 5

Emerging Topical Agents

  • Crisaborole 2% ointment (PDE-4 inhibitor) is approved for mild to moderate eczema in infants aged 3 months and above 1
  • Most common adverse effect is stinging or burning at application site 1

Managing Complications

Secondary Bacterial Infection

  • Watch for crusting, weeping, or worsening despite treatment 2, 5
  • Flucloxacillin is first-choice antibiotic for Staphylococcus aureus infections 4, 5
  • Erythromycin for penicillin-allergic patients 4
  • Avoid long-term topical antibiotics due to resistance and sensitization risk 1

Eczema Herpeticum (Herpes Simplex Infection)

  • Requires prompt treatment with oral acyclovir 4, 5
  • Use intravenous acyclovir for ill, febrile infants 4

Adjunctive Measures

Itch Management

  • Sedating antihistamines may help short-term for sleep disturbance caused by itching, primarily at night 2, 4, 5
  • Non-sedating antihistamines have little value in atopic eczema 2, 4

Trigger Avoidance

  • Use cotton clothing next to skin and avoid wool or synthetic fabrics 2, 4
  • Keep fingernails short to minimize scratching damage 2, 4, 5
  • Maintain comfortable room temperatures, avoiding excessive heat 2
  • Avoid harsh detergents and fabric softeners when washing clothes 2

Wet-Wrap Therapy

  • Effective short-term (3-7 days, maximum 14 days) second-line treatment for moderate to severe eczema with topical corticosteroids 1
  • Should be considered before systemic immunosuppressive therapies 1

Critical Safety Considerations and Pitfalls

Corticosteroid Safety

  • Never use high-potency corticosteroids on infants—risk of systemic absorption and HPA axis suppression is significantly elevated 4, 5
  • Provide only limited quantities with specific instructions on safe application sites 2
  • Avoid abrupt discontinuation of corticosteroids to prevent rebound flares 2
  • Monitor for skin atrophy, striae, or signs of systemic absorption 4

Emollient Safety Concerns

  • Emollients may increase risk of skin infections (17 more cases per 1000 infants) 7
  • Watch for infant slippage hazards when using emollients 7
  • Monitor for stinging or allergic reactions to moisturizers 7
  • Note: Recent high-quality evidence shows emollients do not prevent eczema development and may increase food allergy risk, but they remain essential for treating established eczema 8, 7

Dietary Restrictions

  • Dietary restriction is worth trying only in selected infants under professional supervision with dietitian consultation 2

Parent Education Essentials

  • Demonstrate proper application technique for emollients and medications 2
  • Provide written instructions to reinforce verbal guidance 2
  • Explain that deterioration in previously stable eczema may indicate infection or contact dermatitis 2
  • Reassure parents about safety of appropriate low-potency topical corticosteroid use, as fear of steroids often leads to undertreatment 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Eczema in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Eczema in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Infantile Eczema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Skin care interventions in infants for preventing eczema and food allergy.

The Cochrane database of systematic reviews, 2022

Research

Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT.

Health technology assessment (Winchester, England), 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.